In this issue:
Dose-response antipsychoticbrelationships in acute schizophrenia
Rechallenge of clozapine afterbneutropaenia
Societal costs of schizophrenia
Interventions for schizophrenia withbco-occurring substance use disorders
Prefrontal glutamate in first-episodebpsychosis
Second-generation antipsychotics +bmetformin in non-diabetic adults
Second-generation LAI vs. oralbantipsychotics in pregnancy
Childhood/adolescent loneliness &bschizophrenia
OASIS: long-term outcomes in individuals with clinical high risk for psychosis
Empagliflozin & body weight in atypical antipsychotic-treated schizophrenia
Please login below to download this issue (PDF)